Consensus Conference Statement Bariatric Surgery for Morbid Obesity

Total Page:16

File Type:pdf, Size:1020Kb

Consensus Conference Statement Bariatric Surgery for Morbid Obesity Surgery for Obesity and Related Diseases 1 (2005) 371–381 2004 ASBS Consensus Conference Consensus Conference Statement Bariatric surgery for morbid obesity: Health implications for patients, health professionals, and third-party payers Henry Buchwald, M.D., Ph.D., F.A.C.S. For the Consensus Conference Panel This Consensus Statement on the state of bariatric sur- this assessment is made with the realization that new knowl- gery for morbid obesity has been prepared by a panel of edge, recommendations, and procedures will continue to broadly based and experienced experts based on presenta- emerge through medical research. tions by investigators working in areas relevant to current The Consensus Conference was convened and this Con- questions in this field during a 1½-day public session; ques- sensus Statement was prepared to update the 1991 NIH tions and statements from conference attendees during open Consensus Statement on “Gastrointestinal Surgery for Se- discussion periods that were part of the public sessions; and vere Obesity.” closed deliberations by the panel. This statement is an in- Findings and conclusions of the Consensus Panel in- dependent report of the panel and is not a policy statement clude: of the American Society for Bariatric Surgery or any of the sponsors or endorsers of the Consensus Conference. 1. Bariatric surgery is the most effective therapy avail- Though the Consensus Conference is modeled on the format able for morbid obesity and can result in improve- used by the National Institutes of Health (NIH), the plan- ment or complete resolution of obesity comorbidi- ning, execution, and development of the conference and ties. preparation of this statement were carried out without any 2. Types of operative procedures for morbid obesity relationship with the NIH. In addition, although the Con- have increased since 1991 and are continuously ference was addressed by the Honorable Tommy Thomp- evolving; there are currently four types of proce- son, Secretary of Health and Human Services, this report is dures that can be used to achieve sustained weight not a policy statement of the federal government. loss: gastric bypass (standard, long-limb, and very This statement reflects the panel’s assessment of medical long-limb Roux), alone or in combination with ver- knowledge available at the time it was written. Knowledge tical banded gastroplasty; laparoscopic adjustable about bariatric surgery and morbid obesity is dynamic, and gastric banding; vertical banded gastroplasty; and biliopancreatic diversion and duodenal switch. 3. Both open and laparoscopic bariatric operations are This consensus statement is from the participants and in no way is an endorsement by the Journal of the American College of Surgeons or the effective therapies for morbid obesity and represent American College of Surgeons. complementary state-of-the-art procedures. Cosponsored by the American Society for Bariatric Surgery and the 4. Bariatric surgery candidates should have attempted American Society for Bariatric Surgery Foundation. to lose weight by nonoperative means, including Members of the Consensus Conference Panel are listed in the Appendix at the end of the article. self-directed dieting, nutritional counseling, and Henry Buchwald, MD, PhD, FACS provides consultative services to commercial and hospital-based weight loss pro- Ethicon Endo-Surgery, Inc., a Johnson & Johnson Company, and to Trans- grams, but should not be required to have completed neuronix, Inc. formal nonoperative obesity therapy as a precondi- Presented at the Georgetown University Conference Center, Washing- tion for the operation. ton, DC, May 2004. Correspondence address: Henry Buchwald, 420 Delaware St SE, 5. The bariatric surgery patient is best evaluated andء University of Minnesota, Mayo Mail Code 290, Minneapolis, MN 55455. subsequently cared for by a multidisciplinary team. Reprinted with permission from Buchwald H. Consensus Conference Statement: Bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers. J Am Coll Surg 2005;200:593–604. 372 Reprinted with permission from H. Buchwald, J Am Coll Surg 2005;200:593–604 6. Bariatric surgery candidates should have a compre- Class II (BMI 35.0 kg/m2 to 39.9 kg/m2), and Class III hensive medical evaluation before the operation; (BMI Ն 40 kg/m2). evaluation by subspecialists (eg, cardiologists, psy- Morbid obesity is estimated to afflict 20% of the obese chiatrists, and psychologists) is not routinely needed population or over 8 million of the US population. Indeed, but should be available if indicated. the relative rise of morbid obesity over the already expo- 7. Bariatric surgery, performed only by experienced nential rise of obesity in the past 25 years can be charac- centers, should be considered in morbidly obese terized as an epidemic within an epidemic. Between 1986 adolescents. and 2000, prevalence of obesity (BMI Ն 30 kg/m2) dou- 8. Extending bariatric surgery to patients with Class I bled, morbid obesity (BMI Ն 40 kg/m2) quadrupled, and 2 obesity (body mass index [BMI] 30 to 34.9 kg/m2), super obesity (BMI Ն 50 kg/m ) increased fivefold in US who have a comorbid condition that can be cured or adults. A similar pattern of increasing degrees of obesity has markedly improved by substantial and sustained been demonstrated in the pediatric population. weight loss, may be warranted and requires addi- Obesity should be considered a chronic disease that has tional data and longterm risk and benefit analyses. serious health consequences. An expert panel convened by 9. Bariatric surgery can be cost effective before the 4th the National Heart, Lung and Blood Institute stated that, year of followup. “obesity is a complex multifactorial chronic disease that 10. Bariatric surgery offers rich opportunities for both develops from an interaction of genotype and the environ- basic and translational patient-oriented research to ment.” In 1997, the World Health Organization defined provide a better understanding of the factors in- obesity as “a disease in which excess fat is accumulated to volved in the regulation of food intake, pathophys- an extent that health may be adversely affected.” WHO has iology of obesity, metabolic and clinical effects of listed obesity as a disease condition in its International sustained weight loss, and best treatment options for Classification of Disease since 1979. In the United States, obese persons. the National Center for Health Statistics and the Centers for Medicare and Medicaid Services have assigned obesity a specific ICD-9, clinical modification code of #278.00, and There is a world epidemic of overweight, defined as a morbid obesity, #278.01. BMI Ն 25 to 29.9 kg/m2, and obesity, defined as a BMI Ն Morbid obesity is the harbinger of many other diseases 30 kg/m2, that is estimated to encompass 1.7 billion people. that affect essentially every organ system: cardiovascular According to the Worldwatch Institute, the number of over- (hypertension, atherosclerotic heart and peripheral vascular weight people is approximately equal to the number of disease with myocardial infarction and cerebral vascular underweight people in the world. accidents, peripheral venous insufficiency, thrombophlebi- Approximately two-thirds of the US population is over- tis, pulmonary embolism); respiratory (asthma, obstructive weight, and of these, about one-half are obese; one of four sleep apnea, obesity-hypoventilation syndrome); metabolic adults, or over 50 million people, in the United States are (type 2 diabetes, impaired glucose tolerance, hyperlipid- obese. Prevalence of obesity is particularly high in many emia); musculoskeletal (back strain, disc disease, weight- ethnic minority women, such as African, Mexican, Native, bearing osteoarthritis of the hips, knees, ankles, feet); gas- and Pacific Islander American women. trointestinal (cholelithiasis, gastroesophageal reflux disease, In children and adolescents, overweight is defined by nonalcoholic fatty liver disease [steatosic steatohepatitis], Ն gender- and age-specific BMI 95th percentile on growth hepatic cirrhosis, hepatic carcinoma, colorectal carcinoma); charts determined by the National Center of Health Statis- urologic (stress incontinence); endocrine and reproductive tics. In the United States, overweight tripled in children (polycystic ovary syndrome, increased risk of pregnancy between 1970 and 2000. Approximately, 15% of children and fetal abnormalities, male hypogonadism, cancer of the and adolescents (6 to 19 years old) are overweight. An endometrium, breast, ovary, prostate, pancreas); dermato- estimated 250,000 children and adolescents have a BMI Ն logic (intertriginous dermatitis); neurologic (pseudotumor 95th percentile. Overweight children and adolescents have a cerebri, carpal tunnel syndrome); and psychologic (depres- higher risk of becoming obese adults. sion, eating disorders, body image disturbance). Nearly Morbid obesity, also referred to as “clinically severe 30% of overweight adolescents in the United States meet obesity” or “extreme obesity,” was defined as the criteria for the criteria for metabolic syndrome, which increases risk of bariatric surgery by the 1991 NIH Consensus Conference type 2 diabetes and coronary heart disease. Statement on Gastrointestinal Surgery for Severe Obesity as The impact of obesity on longevity has been well docu- aBMIՆ 40 kg/m2 oraBMIՆ 35 kg/m2 in the presence of mented. In the world, over 2.5 million deaths annually can high-risk comorbid conditions.
Recommended publications
  • Atherosclerosis V ATHERO• SCLEROSIS V
    Atherosclerosis V ATHERO­ SCLEROSIS V Proceedings of the Fifth International Symposium Edited by Antonio M. Gotto, Jr. Louis C. Smith Barbara Allen With 250 illustrations Springer-Verlag New York Heidelberg Berlin Proceedings of the Fifth International Symposium on Atherosclerosis Held in Houston, November 6-9, 1979 Sponsored by Baylor College of Medicine and The Methodist Hospital, Houston, Texas All rights reserved. No part of this book may be translated or reproduced in any form without written permission from Springer-Verlag. The use of general descriptive names, trade names, trademarks, etc. in this publication, even if the former are not especially identified, is not to be taken as a sign that such names, as understood by the Trade Marks and Merchandise Marks Act, may accordingly be used freely by anyone. © 1980 by Springer-Verlag New York Inc. Softcover reprint of the hardcover 1st edition 1980 9 8 7 654 3 2 1 ISBN-13: 978-1-4612-6073-8 e-ISBN-13: 978-1-4612-6071-4 DOl: 10.1007/978-1-4612-6071-4 INTERNATIONAL PROGRAM COMMITTEE Jean-Louis Beaumont David Kritchevsky Henry Buchwald K.T. Lee Lars A. Carlson Kare R. Norum William E. Connor Michael F. Oliver Alan J. Day Rodolfo Paoletti Frederick H. Epstein Gotthard Schettler Yuichiro Goto Gunther Schlierf Antonio M. Gotto, Jr. Yechezkiel Stein M. Daria Haust Daniel Steinberg William L. Holmes Jack P. Strong Anatoli N. Klimov ORGANIZING COMMITTEE Chairman: Antonio M. Gotto, Jr. Co-Chairman: Yuichiro Goto General Secretary: Louis C. Smith Symposium Coordinator: Jean King Scientific Editor: Barbara Allen ACKNOWLEDGEMENTS We gratefully acknowledge the following individuals, institutions, organizations and companies whose generosity and support made this meeting possible.
    [Show full text]
  • Laparoscopic Bariatric Surgery Cadaver Lab
    21 51 Annual Meeting American Society for Bariatric Surgery San Diego Convention Center, San Diego, CA, USA June 12-18, 2004 Dear Colleague, [t is my pleasure to invite you to this year's ASBS Annual Meeting in my hometown, San Diego, California, June 12- 18, 2004. As our Society has grown over the past several years, we have become one of the most important specialties in all of medicine. Our meetings have become bigger and better, and thi s year proves to be the best ever. For the first time our meeting is large enough to be in the San Di ego Convention Center. The headquarters hotel, the San Diego Marri ott, is one of San Diego's most beautiful hotels, located ri ght on the waterfront. We have worked hard to present a plenary session second to none while inviting stimulating thought leaders for in vited lectures. Pay close attenti on to the schedul e as the format has changed somewhat to accommodate our expanding courses and social events. [f thi s is your first or twenty-first meeting, please jo in us for this opportunity to learn , network and sociali ze in one of the most beautiful cities in the world . Alan C. Wittgrove, MD Presid ent GENERAL INFORMATION PURPOSE EDUCATIONAL OBJECTIVES Paper presentations of the most current research and I. To prepare physicians and support staff to define, in vited lectures promote the exchange of information di scuss and solve specific problems in the treatment and ex periences between those practiced in bari atric of morbidly obese patients in order to achi eve surgery and newcomers to the field.
    [Show full text]
  • 6375 ASA Book Page 1 Thursday, March 11, 2010 7:20 AM
    AMERICAN SURGICAL ASSOCIATION Program of the 130th Annual Meeting The Fairmont Chicago, Illinois Thursday, April 8th Friday, April 9th Saturday, April 10th 2010 Program Book Covers ASA 10.indd 1 3/15/2010 3:33:53 PM Table of Contents Officers and Council ‌....................................................................2 Committees ..................................................................................3 Foundation Trustees .....................................................................5 Representatives ............................................................................6 Future Meetings ...........................................................................7 General Information .....................................................................8 Continuing Medical Education Accreditation Information ........10 Program Committee Disclosure List ..........................................13 Faculty Disclosure List ...............................................................13 Author Disclosure List ...............................................................14 Discussant Disclosure List .........................................................22 Schedule-at-a-Glance .................................................................24 Program Outline .........................................................................26 Program Detail and Abstracts .....................................................42 Alphabetical Directory of Fellows .............................................94 Geographic
    [Show full text]
  • Henry Buchwald, M.D., Ph.D. Narrator Lauren Klaffke Interviewer
    Henry Buchwald, M.D., Ph.D. Narrator Lauren Klaffke Interviewer ACADEMIC HEALTH CENTER ORAL HISTORY PROJECT UNIVERSITY OF MINNESOTA ACADEMIC HEALTH CENTER ORAL HISTORY PROJECT In 1970, the University of Minnesota’s previously autonomous College of Pharmacy and School of Dentistry were reorganized, together with the Schools of Nursing, Medicine, and Public Health, and the University Hospitals, into a centrally organized and administered Academic Health Center (AHC). The university’s College of Veterinary Medicine was also closely aligned with the AHC at this time, becoming formally incorporated into the AHC in 1985. The development of the AHC made possible the coordination and integration of the education and training of the health care professions and was part of a national trend which saw academic health centers emerge as the dominant institution in American health care in the last third of the 20th century. AHCs became not only the primary sites of health care education, but also critical sites of health sciences research and health care delivery. The University of Minnesota’s Academic Health Center Oral History Project preserves the personal stories of key individuals who were involved with the formation of the university’s Academic Health Center, served in leadership roles, or have specific insights into the institution’s history. By bringing together a representative group of figures in the history of the University of Minnesota’s AHC, this project provides compelling documentation of recent developments in the history of American health care education, practice, and policy. 2 Biographical Sketch Henry Buchwald was born in Vienna, Austria. His family, fleeing from the Holocaust, came to the United States in 1938.
    [Show full text]
  • Letter from the President
    Published online: 7 July 2010 LETTER FROM THE PRESIDENT Letter of Invitation from Dr. Fobi On behalf of the American Society for Metabolic and Bariatric Surgery, which is hosting this IFSO XV Congress, it is my honor and that of the Co-President of this Congress, Dr Henry Buchwald, to welcome you to Los Angeles/Long Beach for IFSO 2010. The expectations for this Los Angeles/Long Beach Congress are high. Yes, it is the Fobi Congress. Yes, it is where the first international Symposium on Surgical Treatment of Obesity was hosted from 1981 through 1991. Yes, it was The International Symposium on Surgical Treatment of Obesity that brought doctors from all over the world to share their experiences in bariatric surgery. Yes, it was this International Symposium that formed the international camaraderie which was the building base for IFSO. IFSO, since its inception in 1995 in Stockholm, has grown by leaps and bounds. The first Congress in 1996 had 265 attendees, and IFSO 2009 had 1550 attendees. We are planning for 2000 attendees in 2010. The national organizing committee has been working on the program,’ and there have been a lot of suggestions from many on what will make this Congress a must attend’ and the most talked about. The plan is to stage a high quality Congress that is affordable and meets the needs of all attendees. In addition to the posters, videos and paper sessions that will come from abstracts submitted, there will be master lectures, symposiums and roundtable panel discussions and debates. There are post-graduate courses planned on what to do, how to do it and why.
    [Show full text]
  • Bulletin May 2015
    MAY 2015 | VOLUME 100 NUMBER 5 | AMERICAN COLLEGE OF SURGEONS Bulletin Going green in the OR Contents FEATURES COVER STORY: Strategies for sustainability: Going green in the OR 10 Tony Peregrin PreOp program: Can we achieve a “trickle-up” effect? 18 Rachael A. Venn, Stefanie P. Lazow, and Gregory F. Dakin, MD, FACS Surgeons develop visionary plan to bring corneal transplants to developing countries 22 Stephen G. Waller, MD; Maria S. Altieri, MD; and Rahul M. Jindal, MD, PhD, MBA, FACS American College of Surgeons Foundation Annual Report 2014 29 | 1 A PUBLICATION OF THE AMERICAN COLLEGE OF SURGEONS PROFESSIONAL ASSOCIATION (ACSPA) Influencing THE ACS Health Policy in Washington ADVOCATE and the States Each month, rely on the ACS advocacy e-newsletter: To keep you informed To learn the College’s position on pertinent issues To see how your involvement can make a difference. Downloadable from most digital communications devices Visit www.facs.org/publications/newsletters/acs-advocate Advocacy Summit • AMA House of Delegates/Surgical Caucus • Cancer • Chapter Advocacy • Training • Coding • Electronic Health Records • e-Prescribing • Grassroots Efforts • Health Information Technology • Legislative Action Center • Legislative Advocacy • Liability • Lobby Day Grant Program • Medicaid • Medicare • Medicare Physician Payment • Pediatric Issues • Physician Quality Reporting • Political Action Committee (SurgeonsPAC) • Quality and Patient Safety • Relative Value Update Committee (RUC) • Socioeconomics • Surgery State Legislative Action Center (SSLAC) • Surgical Quality Alliance • Trauma and EMS • Workforce ACS Advocate Half Page for Bulletin_2_6_15.indd 1 2/6/2015 11:47:38 AM MAY 2015 BULLETIN American College of Surgeons Contents continued STATEMENTS From the Archives: ACS Archives Disciplinary actions taken 67 houses practice records of Franklin Report on ACSPA/ACS activities, Statement in support of H.
    [Show full text]
  • Walter J. Pories, MD, FACS Professor of Surgery, Biochemistry and Kinesiology
    Walter J. Pories, MD, FACS Professor of Surgery, Biochemistry and Kinesiology Brody School of Medicine, East Carolina University 600 Moye Boulevard, Greenville, NC 27834 252.744.3290 (O), 252.744.3047 (FAX) [email protected]., [email protected] PRESENT POSITION: Director of Bariatric Research Group 1990-present Department of Surgery, East Carolina University Professor of Surgery East Carolina University Greenville, NC 27834 1977-present Professor of Biochemistry East Carolina University 1994-present Adjunct Professor of Kinesiology East Carolina University 2000-present Director, Metabolic Institute East Carolina University 2005-2009 Adjunct Professor of Surgery Uniformed Services University of the Health Sciences Bethesda, Maryland 20814-4799 1984-present Chair, The Laupus Library, Governance and and State Planning Committee 2008- 2009 Graduate Faculty 2008-present East Carolina University Member, Medical Ethics Committee 2009-present Pitt County Memorial Hospital EDUCATION: BA Wesleyan University, Middletown, Connecticut 1952 Graduate Research Fellow in Biochemistry and Radiology, University of Rochester, School of Medicine and Dentistry, Rochester, New York 1952-1954 MD With Honor - University of Rochester, School of Medicine and Dentistry, Rochester, New York 1955 Internship in Surgery and Obstetrics - Strong Memorial Hospital, University of Rochester 1955-1956 Fellow in Head and Neck Cancer (part-time) Centre du Cancer, Universite de Nancy, France 1956-1958 Graduate Research Fellow in Biochemistry Atomic Energy Commission, University of
    [Show full text]
  • Beyond Cardiac Surgery Owen H
    FEATURE he Department of Surgery at the Uni- Owen Wangensteen versity of Minnesota is best known served as chair of the for the development of open-heart Department of Surgery T at the University of surgery, the invention of the pacemaker Minnesota for 37 years, and the emergence of Minnesota’s thriving making it a leader in surgical research and medical device industry known as Medi- facilitating some of the cal Alley. Today, these remarkable events most significant medical triumphs of the 20th are celebrated at the National Museum of century. PHOTO COURTESYPHOTO OF MINNESOTA THE UNIVERSITY American History in Washington D.C. While leading Minnesota figures in cardiac surgery—F. John Lewis, C. Walton Lillehei and Earl Bakken, to name a few— have been honored, much of the credit is also attributed to the singular leadership of department chair Owen Harding Wan- gensteen, who served as the department’s charismatic leader from 1930 to 1967.1 Fostering an atmosphere that emphasized the need for surgical science, he encour- aged surgeons to develop active research agendas in the laboratory. The focus on surgical research and its integration into medical education yielded many impor- tant contributions to mid-century surgery beyond cardiology’s impressive results. Wangensteen presided over an active research program that included the devel- opment of nasogastric suction to manage the surgical complications of bowel ob- struction and Henry Buchwald’s work on cholesterol metabolism and development of bariatric surgery. Moreover, during the Wangensteen era, the stage was set for the pioneering organ transplant work that followed under John Najarian’s tenure as chair during the 1970s.
    [Show full text]
  • Congress Program
    2nd World Congress on Interventional Therapies for Type 2 Diabetes March 28-30, 2011 Hilton New York • New York, NY • USA Congress Director Francesco Rubino, MD Congress Program www.wcidt.org Hosted By Welcome to the 2nd World Congress on Interventional therapies for Type 2 diabetes Dear Colleagues and Friends, Several gastrointestinal (GI) operations originally designed to treat morbid obesity also cause dramatic improvement or even remission of type 2 diabetes. The mechanisms by which surgery controls hyperglycemia remain elusive. Increasing evidence suggests that weight-independent mechanisms may play a role in the surgical control of diabetes. This knowledge challenges current paradigms of disease pathogenesis and points to the gastrointestinal tract as a potential target for the development of less invasive interventional therapies and novel pharmaceuticals. Previously, the Diabetes Surgery Summit (Rome 2007) and the 1st World Congress on Interventional Therapies for Type 2 Diabetes (New York 2008), have raised attention about the role of gastrointestinal surgery for the treatment of diabetes: opportunities and limitations of this emerging field are now the matter of a growing debate. The debate continues with the 2nd World Congress on Interventional Therapies for Type 2 Diabetes. A multidisciplinary group of clinicians, scientists and policy makers will address barriers that still prevent access to surgical treatment of diabetes in eligible patients and develop an agenda of research priorities to improve patients selection and elucidate mechanisms of diabetes control. A stellar Faculty of leading international scientists will also discuss how the lessons learned from study of gastrointestinal interventions may improve understanding of diabetes and provide a lead for future treatments of curative intent.
    [Show full text]